Hematologic Malignancies

domain

Cancers of the blood, bone marrow, and lymphatic system, including leukemias, lymphomas, and multiple myeloma.

108

Centers

18,239

Active Trials

2,004

NIH Grants

$26.5B

NCI Funding

General Cancer Types(631)

NameCenters
LEUKEMIA102
MULTIPLE MYELOMA100
Lymphoma99
Acute Myeloid Leukemia98
ACUTE LYMPHOBLASTIC LEUKEMIA93
Diffuse Large B Cell Lymphoma91
Myelodysplastic Syndrome91
Chronic Lymphocytic Leukemia88
Mantle Cell Lymphoma88
Non Hodgkin Lymphoma84
Refractory Multiple Myeloma82
Myeloproliferative Neoplasm79
Chronic Myelomonocytic Leukemia78
Hodgkin Lymphoma78
B Acute Lymphoblastic Leukemia77
Follicular Lymphoma77
Mixed Phenotype Acute Leukemia74
Refractory Non-Hodgkin Lymphoma72
Secondary Acute Myeloid Leukemia72
Ann Arbor Stage III Hodgkin Lymphoma71
Ann Arbor Stage IV Hodgkin Lymphoma71
Acute Myeloid Leukemia Post Cytotoxic Therapy69
Marginal Zone Lymphoma69
Classic Hodgkin Lymphoma68
Adult B Acute Lymphoblastic Leukemia67
Acute Undifferentiated Leukemia66
Juvenile Myelomonocytic Leukemia65
Myeloid Leukemia65
Recurrent Non-Hodgkin Lymphoma65
Acute Leukemia63
Acute Leukemia of Ambiguous Lineage63
Lymphoblastic Lymphoma63
Myeloid Neoplasm63
Refractory Diffuse Large B Cell Lymphoma61
Recurrent Diffuse Large B-Cell Lymphoma60
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified57
Myelodysplastic Syndrome/Acute Myeloid Leukemia57
Hypodiploid B Acute Lymphoblastic Leukemia56
Acute Myeloid Leukemia, Myelodysplasia-Related55
Anaplastic Large Cell Lymphoma55
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL155
Grade 1 Follicular Lymphoma55
Grade 2 Follicular Lymphoma55
High Grade B-Cell Lymphoma, Not Otherwise Specified55
Langerhans Cell Histiocytosis54
Ann Arbor Stage II Adult Lymphoblastic Lymphoma53
Recurrent Acute Lymphoblastic Leukemia53
Burkitt Lymphoma52
High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements52
Hairy Cell Leukemia51
Classic Follicular Lymphoma50
Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma49
High Grade B Cell Lymphoma45
Lymphoplasmacytic Lymphoma44
Grade 3 Follicular Lymphoma43
DS Stage I Multiple Myeloma42
DS Stage II Multiple Myeloma42
DS Stage III Multiple Myeloma42
Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma42
Refractory B-Cell Non-Hodgkin Lymphoma42
Enteropathy Associated T-cell Lymphoma41
Plasma Cell Neoplasm41
High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements40
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma40
Adult Immunoblastic Lymphoma39
Central Nervous System Non-Hodgkin Lymphoma39
Grade 3a Follicular Lymphoma38
Plasmablastic Lymphoma38
Myelodysplastic/Myeloproliferative Neoplasm37
Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type36
B-Cell Non-Hodgkin Lymphoma33
Ann Arbor Stage I Lymphoma32
Ann Arbor Stage II Lymphoma32
Ann Arbor Stage III Lymphoma32
Ann Arbor Stage IV Lymphoma32
Chronic Myeloid Leukemia, BCR-ABL1 Positive30
Myeloid-Derived Suppressor Cell29
Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type29
Recurrent B-Cell Non-Hodgkin Lymphoma29
Adult T Cell Leukemia/Lymphoma27
Lymphocytic Leukemia27
Central Nervous System Lymphoma26
Adult Acute Myeloid Leukemia25
Indolent Non-Hodgkin Lymphoma23
Primary Mediastinal Large B Cell Lymphoma22
Adult Grade III Lymphomatoid Granulomatosis19
Indolent Systemic Mastocytosis19
AIDS Related Lymphoma18
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma18
Systemic Mastocytosis18
Adult Acute Lymphoblastic Leukemia16
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements14
Acute Biphenotypic Leukemia12
Acute Myeloid Leukemia in Remission12
Aggressive Non-Hodgkin Lymphoma12
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue12
Non-Hodgkin Lymphomas12
Acute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH1111
Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T111
Accelerated Phase Myeloproliferative Neoplasm10
Adult Non-Hodgkin Lymphoma10
Blast Phase Myeloproliferative Neoplasm10
CLL (Chronic Lymphocytic Leukemia)10
Core Binding Factor Acute Myeloid Leukemia10
Mastocytosis10
MDS (Myelodysplastic Syndrome)10
Myeloproliferative Neoplasms (MPN)10
Ann Arbor Stage I Hodgkin Lymphoma9
Ann Arbor Stage II Hodgkin Lymphoma9
Acute Lymphoid Leukemia (ALL)8
Acute Myeloid Leukemia With KMT2A Rearrangement8
Indolent B-Cell Non-Hodgkin Lymphoma8
Peripheral T-cell Lymphomas8
AIDS-Related Non-Hodgkin Lymphoma7
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma7
Primary Central Nervous System Lymphoma7
AIDS-Related Diffuse Large B-cell Lymphoma6
AML - Acute Myeloid Leukemia6
Anaplastic Lymphoma Kinase6
Acute Leukemia in Remission5
Adult Burkitt Lymphoma5
Adult Hodgkin Lymphoma5
Adult Lymphoblastic Lymphoma5
Aggressive B-Cell Non-Hodgkin Lymphoma5
Chronic Leukemia5
Leukemia Acute Myeloid Leukemia (AML)5
Recurrent Lymphoplasmacytic Lymphoma5
Stage 0 Chronic Lymphocytic Leukemia5
T-cell Leukemia/Lymphoma5
Acute Megakaryoblastic Leukemia4
Aggressive B-cell Lymphoma4
Burkitt Leukemia4
Mature B-Cell Non-Hodgkin Lymphoma4
Monocytic Leukemia4
Non-Hodgkin's Lymphomas4
Refractory Lymphoplasmacytic Lymphoma4
Smoldering Multiple Myeloma (SMM)4
Acute Monocytic Leukemia3
Adult Acute Promyelocytic Leukemia (M3)3
Adult T Cell Leukemia3
Anaplastic Lymphoma Kinase (ALK) Positive3
Ann Arbor Stage II Noncutaneous Anaplastic Large Cell Lymphoma3
Ann Arbor Stage III Noncutaneous Anaplastic Large Cell Lymphoma3
Ann Arbor Stage IV Noncutaneous Anaplastic Large Cell Lymphoma3
B-cell Non-Hodgkin Lymphomas3
B-precursor Acute Lymphoblastic Leukemia3
Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive3
Chronic Lymphocytic Leukemia in Relapse3
CNS Lymphoma3
Cutaneous T-Cell Lymphoma Refractory3
Diffuse Large B Cell Lymphoma in Relapse3
Diffuse Large B-Cell Lymphoma, Lymphoma Follicular3
Hairy Cell Leukemia Variant3
IDH1 Mutation Myeloid Neoplasms3
Lymphomatoid Papulosis3
Mantle Cell Lymphoma in Relapse3
Mediastinal Large B-cell Lymphoma3
Multiple Myeloma Bone Disease3
Other B Cell Lymphoma in Relapse3
Patients With Multiple Myeloma Experiencing a3
Peripheral T-Cell Lymphoma Refractory3
Philadelphia Positive Adult Acute Lymphoblastic Leukemia3
Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes3
Recurrent B-Cell Prolymphocytic Leukemia3
Recurrent Chronic Myeloid Leukemia, BCR-ABL1 Positive3
Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma3
Refractory B-Cell Prolymphocytic Leukemia3
Refractory Chronic Myeloid Leukemia, BCR-ABL1 Positive3
Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified3
Relapse Leukemia3
Relapsed Acute Myelogenous Leukemia3
Relapsed Adult Acute Myeloid Leukemia3
Relapsed or Refractory Chronic Myelomonocytic Leukemia3
Relapsed or Refractory Myelodysplastic Syndrome3
714leukemia2
Acute Erythroid Leukemia2
Acute Lymphoblastic Leukaemia2
Acute Lymphoblastic Leukemia With Failed Remission2
Acute Lymphoblastic Leukemia, in Relapse2
Acute Lymphoblastic Leukemias2
Acute Lymphoblastic Lymphoma2
Acute Lymphocytic Leukaemia2
Acute Lymphoid Leukemia, Disease (disorder)2
Acute Myeloblastic Leukemia2
Acute Myeloid Leukaemia2
Acute Myeloid Leukaemia Refractory2
Acute Promyelocytic Leukemia (APL)2
Adult Diffuse Large B-Cell Lymphoma2
Adult Myelodysplastic Syndrome2
Advanced Malignant Tumors Lymphomas2
Advanced Myelodysplastic Syndromes2
Agnogenic Myeloid Metaplasia2
AIDS-Related Hodgkin Lymphoma2
AIDS-related Peripheral/Systemic Lymphoma2
AIDS-related Primary CNS Lymphoma2
ALK-negative Anaplastic Large Cell Lymphoma2
B-Cell Acute Lymphoblastic Leukemia, Adult2
B-Cell Diffuse Lymphoma2
Biphenotypic Acute Leukemia2
Cancer - Acute Myeloid Leukemia2
Chronic Lymphocytic Leukemia in Remission2
Chronic Lymphoid Leukemia2
Chronic Myeloid Leukemia - Accelerated Phase2
Chronic Myeloid Leukemia Accelerated Phase (CML-AP, Ph+)2
Chronic Myeloid Leukemia Blast Crisis (CML-BC, Ph+)2
Cutaneous Lymphoma2
Cutaneous T Cell Lymphomas (CTCL)2
Cutaneous T-Cell Lymphoma Recurrent2
Diffuse Well-differentiated Lymphocytic Lymphoma2
EBV-induced Lymphomas2
Follicular Lymphoma Grade IIIa2
Follicular Lymphoma, Grade 12
Follicular Lymphoma, Grade 22
Follicular Lymphomas2
High Risk Smoldering Multiple Myeloma2
High-risk Myelodysplastic Syndrome (MDS)2
Higher Risk Myelodysplastic Syndromes2
Hodgkin or Non-Hodgkin Lymphoma2
Hodgkin's Lymphoma, Relapsed, Adult2
ISS Stage III Plasma Cell Myeloma2
Large Cell Lymphoma, Diffuse2
Leukemia-Lymphoma, Adult T-Cell2
Leukemia, Acute2
Leukemia, Acute Lymphoblastic2
Leukemia, Acute Myeloid (AML), Child2
Leukemia, Chronic Lymphocytic2
Leukemia, Lymphoblastic (Acute)2
Leukemia, Mast Cell2
Leukemia, T-Cell2
LGL Leukemia2
Lymphoma, AIDS-Related2
Lymphomas Non-Hodgkin&Amp;Amp;#39;s B-Cell2
Lymphomatous Adult T-Cell Leukemia/Lymphoma2
Mantle Cell Lymphomas2
Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate2
Multiple Myeloma and Malignant Plasma Cell Neoplasms2
Myelitis2
Myelitis, Transverse2
Myelodysplastic Neoplasms2
Myelofibrosis With Myeloid Metaplasia2
Myeloproliferative Neoplasm With 10% Blasts or Higher2
Myeloproliferative Syndromes2
Neoplasms, Myelogenous Leukemia, Acute2
Newly Diagnosed Multiple Myeloma2
Non-Hodgkin Lymphoma, Adult2
Non-Hodgkin Lymphoma, Refractory2
Non-Hodgkin Lymphoma, Relapsed2
Non-Hodgkin's Lymphoma (disorder)2
Non-Hodgkin's Lymphoma Refractory2
Non-Hodgkin's Lymphoma, Relapsed2
Non-Hodgkins Lymphoma (NHL)2
Osteomyelitis2
Peripheral T-Cell Lymphoma Recurrent2
Ph+ Acute Lymphoblastic Leukemia (Ph+ALL)2
Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia2
Previously Untreated Peripheral T-cell Lymphoma2
Primary Effusion Lymphomas2
Primary Mediastinal Lymphoma2
Recurrent Aggressive Adult Non-Hodgkin Lymphoma2
Recurrent Angioimmunoblastic T-Cell Lymphoma2
Recurrent Enteropathy-Associated T-Cell Lymphoma2
Recurrent Hepatosplenic T-Cell Lymphoma2
Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma2
Recurrent Myelodysplastic/Myeloproliferative Neoplasm2
Recurrent Myeloproliferative Neoplasm2
Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified2
Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma2
Recurrent Secondary Acute Myeloid Leukemia2
Recurrent Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma2
Refractory Acute Myelogenous Leukemia2
Refractory Angioimmunoblastic T-Cell Lymphoma2
Refractory Enteropathy-Associated T-Cell Lymphoma2
Refractory Hepatosplenic T-Cell Lymphoma2
Refractory Myelodysplastic/Myeloproliferative Neoplasm2
Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma2
Refractory Secondary Acute Myeloid Leukemia2
Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma2
Relapse Diffuse Large B Cell Lymphoma2
Relapsed Acute Myelomonocytic Leukemia2
Relapsed B-Cell Acute Lymphoblastic Leukemia2
Relapsed Classical Hodgkin Lymphoma2
Relapsed Large Cell Lymphoma2
Relapsed Marginal Zone Lymphoma2
Relapsed/Refractory Aggressive B-Cell Lymphoma2
Relapsed/Refractory Large B Cell Lymphoma2
Relapsed/Refractory Lymphomas2
Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL)2
Secondary Central Nervous System Lymphoma2
Small-Cell Lymphoma2
Smoldering Adult T-Cell Leukemia/Lymphoma2
Stage IV Lymphoma2
Systemic Mastocytosis, Aggressive (ASM)2
Transformed Recurrent Non-Hodgkin Lymphoma2
Waldenstrom's Macroglobulinemia (WM)2
Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive1
Acute Lymphatic Leukemia1
Acute Lymphoblastic Leukemia, Adult1
Acute Lymphoblastic Leukemia, Mature B-Cell1
Acute Lymphoblastic Leukemia, Refractory1
Acute Myelocytic Leukemia1
Acute Myeloid Leukemia (AML) in Remission1
Acute Myeloid Leukemia in Children1
Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)1
Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLL1
Acute Myeloid Leukemia, Adult1
Acute Myeloid Leukemia, Relapsed, Adult1
Acute Myeloid/Lymphoblastic Leukemia1
Adult Acute Lymphoblastic Leukemia in Complete Remission1
Adult Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA1
Adult T Cell Leukemia (ATL)1
Adult T Cell Lymphoma1
Adult T Lymphoblastic Lymphoma1
Advanced Myelodysplastic Syndrome1
Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma1
ALK-Positive Anaplastic Large Cell Lymphoma1
Anaplastic Large Cell Lymphoma, T Cell and Null Cell Type1
Anaplastic Lymphoma Kinase Genomic Tumor Aberrations1
Anaplastic Lymphoma Kinase Positive Large B-Cell Lymphoma1
Angioimmunoblastic T-Cell Lymphoma Recurrent1
Angioimmunoblastic T-Cell Lymphoma Refractory1
Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma1
Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma1
Ann Arbor Stage III Follicular Lymphoma1
Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma1
Ann Arbor Stage IV Follicular Lymphoma1
Any Solid Tumor or Lymphoma1
Atypical Burkitt Lymphoma1
B Chronic Lymphocytic Leukemia1
B-Cell Chronic Lymphocytic Leukemia (B-CLL)1
B-Cell Lymphoblastic Leukemia1
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma1
Biphenotypic/Undifferentiated Leukemia1
Biphenotypic/Undifferentiated/Prolymphocytic Leukemias1
CD19+ Diffuse Large B-cell Lymphomas1
CD30-Positive Diffuse Large B-Cell Lymphoma1
CD30-positive Lymphoma1
CD79 Mutant or ABC-subtype Diffuse Large B-Cell Lymphoma1
Chronic Eosinophilic Leukemia-not Otherwise Specified1
Chronic Lymphocytic B-Leukemia1
Chronic Myelocytic Leukemia1
Chronic Myelogenous Leukemia in Blast Crisis1
Chronic Myeloid Leukemia (CML-BP)1
Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive1
Chronic Myeloproliferative Disease1
CNS Leukemia1
Cutaneous T-Cell Lymphoma, Relapsed1
Diffuse Large B Cell Lymphoma of Breast1
Diffuse Large B Cell Lymphoma of Testis1
Diffuse Large B-Cell Lymphoma and Follicular Lymphoma1
Diffuse Large Cell Non Hodgkins Lymphoma1
EBV Positive Plasma Cell Neoplasm1
EBV Related Hodgkin's Lymphoma1
EBV Related Lymphoma1
EBV Related Non-Hodgkin's Lymphoma1
Epstein-Barr Virus-Related Hodgkin Lymphoma1
Epstein-Barr Virus-Related Non-Hodgkin Lymphoma1
Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type1
Extranodal NK T Cell Lymphoma1
Extranodal NK T Cell Lymphoma, Nasal1
Familial Acute Myeloid Leukemia1
Follicular Non-Hodgkin's Lymphoma1
Gray Zone Lymphoma1
High Grade B-Cell Lymphoma w/MYC & BCL2 or BCL6 Rearrangements1
High Grade B-Cell Lymphoma w/MYC, BCL2 & BCL6 Rearrangements1
High Grade Non-Hodgkin's Lymphoma, Adult1
High Risk Acute Leukemia1
High Risk Myeloid Malignancies1
High Risk Undifferentiated Acute Leukemia1
High-risk Myelodysplastic Syndromes1
Histiocytic Neoplasms1
Histiocytic Sarcoma (HS)1
HIV-associated Diffuse Large B Cell Lymphoma1
Indolent Adult Non-Hodgkin Lymphoma1
Intestinal T-Cell Lymphoma1
ISS Stage I Plasma Cell Myeloma1
ISS Stage II Plasma Cell Myeloma1
Large Cell Non-Hodgkin's Lymphoma1
Large Granular Lymphocyte Leukemia1
Leukemia or MDS in Aplasia1
Leukemia, Acute Lymphocytic (ALL)1
Leukemia, Chronic Myeloid1
Leukemia, Lymphocytic, Acute, T-Cell1
Leukemia, Lymphoid, Acute1
Leukemia, Myelogenous, Acute1
Leukemia, Myeloid, Acute(AML)1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative1
Leukemia, Myeloid, Chronic(CML)1
Leukemia, Myelomonocytic, Acute1
Leukemia, Nonlymphocytic, Acute1
Leukemia, Prolymphocytic1
Leukemia, Promyelocytic, Acute1
Leukemia, Small Lymphocytic1
Low Grade B-cell Lymphoma, Not Otherwise Specified1
Lymphoblastic Leukemia in Children1
Lymphoblastic Lymphoma, in Relapse1
Lymphoblastic Lymphoma, Refractory1
LYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL)1
Lymphoma Cancer1
Lymphoma Cns1
Lymphoma, Diffuse1
Lymphoma, Intermediate-Grade1
Lymphoma, Lymphoplasmacytoid, CLL1
Lymphoma, Mixed-Cell1
Lymphoma, Non-Hodgkin Lymphoma, B-Cell1
Lymphoma, Small-Cell1
Lymphomatous Malignancies1
Lymphoplasmacytoid Lymphoma, CLL1
Mature B-Cell Lymphoma1
MDS/Myeloproliferative Neoplasm-unclassifiable (MDS/MPN-unclassifiable)1
Mediastinal B-Cell Diffuse Large Cell Lymphoma1
Mediastinal Lymphoma1
Mediastinal Lymphomas1
Mixed Phenotype Acute Leukemia (MPAL)1
MRD Positive Leukemia1
Multiple Myeloma Progression1
Multiple Myeloma Stage III1
Multiple Myeloma, Refractory to Standard Treatment1
Multiple Myeloma, Relapsed1
Multiple Myeloma, Smoldering1
Myelodysplastic and Myeloproliferative Disorders1
Myelodysplastic Disorders1
Myelodysplastic Syndrome Other1
Myelodysplastic Syndrome RAEB-I or RAEB-II1
Myelodysplastic Syndrome With Low-grade Lesions1
Myelodysplastic Syndrome With Ring Sideroblasts1
Myelodysplastic Syndrome-Refractory Anemia With Excess Blasts1
Myelodysplastic Syndromes, de Novo1
Myelodysplastic Syndromes, Previously Treated1
Myelodysplastic Syndromes, Secondary1
Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis1
Myelodysplastic/Myeloproliferative Overlapping Syndrome1
Myeloid and Monocytic Leukemia1
Myeloid Hematologic Malignancy1
Myeloid Hematological Malignancies1
Myeloid Leukemia in Relapse (Disorder)1
Myeloproliferative Disorders (MPD)1
Myeloproliferative Neoplasm, Unclassifiable1
Myeloproliferative Neoplasms/Myelofibrosis1
Newly Diagnosed Multiple Myeloma (NDMM)1
NHL - Non-Hodgkin&Amp;#39;s Lymphoma1
NK-Cell Leukemia1
NK/T-Cell Lymphoma of Nasal Cavity (Diagnosis)1
NK/T-Cell Lymphoma of Nasopharynx (Diagnosis)1
Non-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell Lymphomas1
Peripheral T-cell Lymphoma NOS1
Philadelphia Chromosome Positive (Ph+) Leukemias1
Philadelphia Chromosome-Positive Chronic Myeloid Leukemia1
Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia1
Philadelphia Positive Chronic Myeloid Leukemia1
Plateau Phase Multiple Myeloma1
Primary Central Nervous System (CNS) Lymphoma1
Primary CNS Lymphoma1
Prolymphocytic Lymphoma1
Recurrent Central Nervous System Lymphoma1
Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma1
Recurrent Chronic Lymphoid Leukemia1
Recurrent Chronic Myelomonocytic Leukemia1
Recurrent Classical Hodgkin Lymphoma1
Recurrent Extranodal Marginal Zone Lymphoma1
Recurrent High Risk Myelodysplastic Syndrome1
Recurrent Lymphoma, Mantle-Cell1
Recurrent/Refractory Secondary Central Nervous System Lymphoma1
Refractory Acute Lymphoid Leukemia in Relapse1
Refractory Adult Acute Myeloid Leukemia1
Refractory B-Cell Lymphoma1
Refractory B-Cell Small Lymphocytic Lymphoma1
Refractory Central Nervous System Lymphoma1
Refractory CML Myeloid Blast Crisis1
Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma1
Refractory Extranodal Marginal Zone Lymphoma1
Refractory High Risk Myelodysplastic Syndrome1
Refractory Plasmablastic Lymphoma1
Refractory T-Cell Lymphoma1
Refractory/Relapse Acute Myeloid Leukemia1
Relapse/Refractory Multiple Myeloma1
Relapsed and Refractory T-cell Lymphoma1
Relapsed Marginal B-cell Lymphoma1
Relapsed Myelodysplastic Syndrome1
Relapsed or Refractory B Cell Non-Hodgkin Lymphoma1
Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma1
Relapsed or Refractory CD19+ B-cell Lymphoma1
Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)1
Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma1
Relapsed or Refractory Small Lymphocytic Lymphoma1
Relapsed Plasmablastic Lymphoma1
Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)1
Sarcoma, Myeloid1
Secondary Myelofibrosis in Myeloproliferative Disease1
Smoldering Waldenstrom Macroglobulinemia1
Smoldering Waldenstrom Macroglobulinemia(WM)1
Solid Tumor, Adult Lymphoma1
Stage III High Grade B-Cell Lymphoma1
Stage III Lymphoma1
Stage III Non-Hodgkin Lymphoma1
Stage IV High Grade B-Cell Lymphoma1
Stage IV Non-Hodgkin Lymphoma1
Systemic Mastocytosis With an Associated Hematological Neoplasm1
T-Cell Leukemia/Lymphoma, Adult1
T-cell Non-Hodgkin's Lymphoma1
T-non-Hodgkin Lymphoma1
Transformed Indolent Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma1
Transplant Patients With EBV Viremia at High Risk for Developing a Recurrent EBV Lymphoma1
Transplant Patients With EBV Viremia at High Risk of Developing a Recurrent EBV Lymphoma1
Treatment-Related Acute Myeloid Leukemia1
Acute Basophilic Leukemia—
Acute Eosinophilic Leukemia—
Acute Monoblastic Leukemia—
Acute Myeloid Leukemia due to Lineage Switch from Acute Leukemia of Ambiguous Lineage—
Acute Myeloid Leukemia due to Lineage Switch from B Acute Lymphoblastic Leukemia, KMT2A-Rearranged—
Acute Myeloid Leukemia due to Lineage Switch from Mixed Phenotype Acute Leukemia—
Acute Myeloid Leukemia with Genetic Abnormalities—
Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11—
Acute Myeloid Leukemia with Maturation—
Acute Myeloid Leukemia with Minimal Differentiation—
Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities—
Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations—
Acute Myeloid Leukemia with Other Genetic Abnormalities—
Acute Myeloid Leukemia with Recurrent Genetic Abnormalities—
Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11—
Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A—
Acute Myeloid Leukemia without Maturation—
Acute Myeloid Leukemia, Not Otherwise Specified—
Acute Myelomonocytic Leukemia—
Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA—
Adult Acute Erythroid Leukemia—
Adult Anaplastic Large Cell Lymphoma—
Adult Classic Hodgkin Lymphoma—
Adult Diffuse Large Cell Lymphoma—
Adult Diffuse Mixed Cell Lymphoma—
Adult Diffuse Small Cleaved Cell Lymphoma—
Adult Hodgkin Lymphoma by Ann Arbor Stage—
Adult Lymphoma—
Adult T-Cell Leukemia/Lymphoma by Ann Arbor Stage—
Advanced Phase Myeloproliferative Neoplasm—
Aggressive Adult Non-Hodgkin Lymphoma—
Aggressive T-Cell Non-Hodgkin Lymphoma—
AIDS-Related Lymphoma by Working Formulation—
Aleukemic Leukemia—
Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma—
Ann Arbor Stage I Burkitt Lymphoma—
Ann Arbor Stage I Follicular Lymphoma—
Ann Arbor Stage I Non-Hodgkin Lymphoma—
Ann Arbor Stage II Adult Burkitt Lymphoma—
Ann Arbor Stage II Adult Immunoblastic Lymphoma—
Ann Arbor Stage II Adult Non-Hodgkin Lymphoma—
Ann Arbor Stage II Burkitt Lymphoma—
Ann Arbor Stage II Grade 1 Follicular Lymphoma—
Ann Arbor Stage II Grade 2 Follicular Lymphoma—
Ann Arbor Stage II Grade 3 Follicular Lymphoma—
Ann Arbor Stage II Mantle Cell Lymphoma—
Ann Arbor Stage II Mature T- and NK-Cell Lymphoma—
Ann Arbor Stage III Burkitt Lymphoma—
Ann Arbor Stage III Mature T- and NK-Cell Lymphoma—
Ann Arbor Stage IV Burkitt Lymphoma—
Ann Arbor Stage IV Mature T- and NK-Cell Lymphoma—
B Acute Lymphoblastic Leukemia with Recurrent Genetic Abnormalities—
Chronic Leukemia in Remission—
Chronic Lymphocytic Leukemia- Modified Rai Staging System—
Chronic Myelomonocytic Leukemia-0—
Colorectal Lymphoma—
Cutaneous Follicular Lymphoma—
Diffuse Large B-Cell Lymphoma of the Central Nervous System—
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile—
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes—
Diffuse Malignant Lymphoma—
Diffuse Mixed Cell Lymphoma—
Digestive System Follicular Lymphoma—
Digestive System Lymphoma—
Digestive System Non-Hodgkin Lymphoma—
Extranodal Non-Hodgkin Lymphoma—
Eye Lymphoma—
Follicular Helper T-Cell Lymphoma—
Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type—
High Grade Lymphoma—
High Risk Chronic Myelomonocytic Leukemia—
Indolent T-Cell Non-Hodgkin Lymphoma—
Intestinal Lymphoma—
L1 Acute Lymphoblastic Leukemia—
Leukemia (Antiquated)—
Leukemia Finding—
Leukemic Phase of Non-Hodgkin Lymphoma—
Low Grade Lymphoma—
Lugano Classification Adult Hodgkin Lymphoma by AJCC v8 Stage—
Lymphocyte-Depleted Classic Hodgkin Lymphoma—
Lymphocytic Neoplasm—
Lymphoma by Ann Arbor Stage—
Lymphoma by Site—
Lymphoma by Working Formulation (Antiquated)—
Lymphoma in Remission—
Lymphomatoid Granulomatosis—
Lymphomatous Involvement of Extranodal Site—
Malignant Lymphoma by Cell Type (Working Formulation)—
Malignant Mastocytosis—
Mature T Cell Lineage Lymphoma of the Mouse Hematologic System—
Mixed Cellularity Classic Hodgkin Lymphoma—
Mouse Myeloid Cell Neoplasm—
Mouse Myeloid Leukemia—
Mouse Myeloid Proliferation—
Mouse Plasma Cell Neoplasm—
Mouse Thyroid Lymphoma—
Multiple Myeloma by ISS Stage—
Multiple Myeloma by RISS Stage—
Multiple Myeloma Myeloma by DS Stage—
Myelodysplastic Syndrome with Genetic Abnormalities—
Myelodysplastic Syndrome, Not Otherwise Specified—
Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia—
Myeloid Dysplasia of Mouse—
Myeloid Neoplasm Finding—
Myeloid Neoplasm Post Cytotoxic Therapy—
Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions—
NCI CTEP SDC Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma) Category Terminology—
NCI CTEP SDC Hematopoietic Neoplasm/Leukemia Category Terminology—
Nodular Sclerosis Classic Hodgkin Lymphoma—
Non-Hodgkin Lymphoma by Clinical Course—
Personal History of Leukemia—
Plasma Cell Neoplasm Finding—
Plasma Cell Neoplasm in Remission—
Prostate Non-Hodgkin Lymphoma—
Recurrent Aggressive T-Cell Non-Hodgkin Lymphoma—
Recurrent Chronic Leukemia—
Refractory Aggressive T-Cell Non-Hodgkin Lymphoma—
Refractory Chronic Leukemia—
Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma—
Refractory Mature B-Cell Non-Hodgkin Lymphoma—
Regimen Used to Treat Lymphocytic Neoplasm—
Regimen Used to Treat Non-Hodgkin Lymphoma—
Stage II Adult Diffuse Large Cell Lymphoma—
Stage II Adult Diffuse Mixed Cell Lymphoma—
Stage II Adult Diffuse Small Cleaved Cell Lymphoma—
TdT Positive Acute Lymphoblastic Leukemia—
Therapy-Related Leukemia—

Top Centers for Hematologic Malignancies(108)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Memorial Sloan Kettering Cancer CenterNew York, NY
NCI Comprehensive
High-Volume Research Center
72.9
2
Karmanos Cancer InstituteDetroit, MI
NCI Comprehensive
High-Volume Research Center
72.2
3
Boston University Cancer CenterBoston, MA
High-Volume Research Center
70.0
4
Fred Hutch Cancer CenterSeattle, WA
NCI Comprehensive
High-Volume Research Center
70.0
5
The University of Texas MD Anderson Cancer CenterHouston, TX
NCI Comprehensive
High-Volume Research Center
70.0
6
University of Colorado Cancer CenterAurora, CO
NCI Comprehensive
High-Volume Research Center
70.0
7
Moffitt Cancer CenterTampa, FL
NCI Comprehensive
High-Volume Research Center
70.0
8
Fred & Pamela Buffett Cancer CenterOmaha, NE
NCI Clinical
Active Research Program
66.0
9
University of Illinois Cancer CenterChicago, IL
Active Research Program
66.0
10
Tampa General Hospital Cancer InstituteTampa, FL
Active Research Program
66.0
11
Duke Cancer InstituteDurham, NC
NCI Comprehensive
Active Research Program
66.0
12
University of Virginia Cancer CenterCharlottesville, VA
NCI Comprehensive
Active Research Program
66.0
13
Louisiana Cancer Research CenterNew Orleans, LA
Active Research Program
66.0
14
Cancer Center at IllinoisUrbana, IL
Active Research Program
59.2
15
Penn State Cancer InstituteHershey, PA
Active Research Program
59.2
16
University of Cincinnati Cancer CenterCincinnati, OH
Active Research Program
59.2
17
Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL
Active Research Program
59.2
18
Georgia Cancer Center, Augusta UniversityAugusta, GA
Active Research Program
59.2
19
Princess Margaret Cancer CentreToronto, ON
Active Research Program
59.2
20
Dana-Farber Cancer InstituteBoston, MA
NCI Comprehensive
Active Research Program
59.2
21
Mayo Clinic Comprehensive Cancer CenterRochester, MN
NCI Comprehensive
Active Research Program
59.2
22
Sylvester Comprehensive Cancer CenterMiami, FL
NCI Clinical
Active Research Program
59.2
23
The University of Arizona Cancer CenterTucson, AZ
NCI Comprehensive
Active Research Program
59.2
24
Cleveland Clinic Cancer CenterCleveland, OH
Active Research Program
59.2
25
University of Hawai‘i Cancer CenterHonolulu, HI
NCI Clinical
Active Research Program
59.2
26
Stanford Cancer InstitutePalo Alto, CA
NCI Comprehensive
Active Research Program
59.2
27
Winship Cancer InstituteAtlanta, GA
NCI Comprehensive
Active Research Program
45.0
28
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
Active Research Program
45.0
29
Medical College of Wisconsin Cancer CenterMilwaukee, WI
Active Research Program
45.0
30
Dartmouth Cancer CenterLebanon, NH
NCI Comprehensive
Active Research Program
45.0
31
University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM
NCI Comprehensive
Active Research Program
45.0
32
UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR
Active Research Program
45.0
33
Stony Brook Cancer CenterStony Brook, NY
Active Research Program
45.0
34
Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ
Active Research Program
45.0
35
University of Puerto Rico Comprehensive Cancer CenterSan Juan, PR
Active Research Program
45.0
36
Loma Linda University Cancer CenterLoma Linda, CA
Active Research Program
45.0
37
Yale Cancer Center Yale School of MedicineNew Haven, CT
NCI Comprehensive
Active Research Program
45.0
38
Vanderbilt-Ingram Cancer CenterNashville, TN
NCI Comprehensive
Active Research Program
45.0
39
The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL
NCI Comprehensive
Active Research Program
45.0
40
OHSU Knight Cancer InstitutePortland, OR
NCI Comprehensive
Active Research Program
45.0
41
Comprehensive Cancer Center St. Jude Children’s Research HospitalMemphis, TN
NCI Comprehensive
Active Research Program
45.0
42
The University of Kansas Cancer CenterKansas City, KS
NCI Comprehensive
Active Research Program
45.0
43
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
45.0
44
Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX
Active Research Program
45.0
45
University of Texas Medical Branch Cancer CenterGalveston, TX
Active Research Program
45.0
46
UCSF Helen Diller Family Comprehensive Cancer CenterSan Francisco, CA
NCI Comprehensive
Active Research Program
45.0
47
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD
NCI Comprehensive
Active Research Program
45.0
48
UPMC Hillman Cancer CenterPittsburgh, PA
NCI Comprehensive
Active Research Program
45.0
49
Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX
NCI Comprehensive
Active Research Program
45.0
50
Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY
NCI Comprehensive
Active Research Program
45.0
51
O’Neal Comprehensive Cancer Center at the University of Alabama at BirminghamBirmingham, AL
NCI Comprehensive
Active Research Program
45.0
52
UF Health Cancer InstituteGainesville, FL
NCI Clinical
Active Research Program
45.0
53
City of Hope Comprehensive Cancer CenterDuarte, CA
NCI Comprehensive
31.9
54
Case Comprehensive Cancer CenterCleveland, OH
NCI Comprehensive
31.9
55
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
31.9
56
BC CancerVancouver, BC
31.9
57
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
31.9
58
Huntsman Cancer Institute at the University of UtahSalt Lake City, UT
NCI Comprehensive
31.9
59
Koch Institute for Integrative Cancer Research at MITCambridge, MA
NCI Basic_laboratory
31.9
60
Siteman Cancer CenterSt. Louis, MO
NCI Comprehensive
31.9
61
Purdue University Institute for Cancer ResearchWest Lafayette, IN
NCI Basic_laboratory
31.9
62
Cardinal Bernardin Cancer CenterMaywood, IL
31.9
63
Roswell Park Comprehensive Cancer CenterBuffalo, NY
NCI Comprehensive
—
64
Holden Comprehensive Cancer CenterIowa City, IA
NCI Comprehensive
—
65
Atrium Health Wake Forest Baptist Comprehensive Cancer CenterWinston-Salem, NC
NCI Comprehensive
—
66
The Jackson Laboratory Cancer CenterBar Harbor, ME
NCI Basic_laboratory
—
67
The University of Vermont Cancer CenterBurlington, VT
—
68
Northwell Health Cancer InstituteNew York, NY
—
69
Dan L Duncan Comprehensive Cancer Center at Baylor College of MedicineHouston, TX
NCI Comprehensive
—
70
University of Wisconsin Carbone Cancer CenterMadison, WI
NCI Comprehensive
—
71
Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis, IN
NCI Comprehensive
—
72
Cedars-Sinai CancerLos Angeles, CA
—
73
VCU Massey Comprehensive Cancer CenterRichmond, VA
NCI Comprehensive
—
74
UMass Memorial Health Cancer CenterWorcester, MA
—
75
Wilmot Cancer Institute, UR MedicineRochester, NY
NCI Clinical
—
76
Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA
NCI Comprehensive
—
77
Livestrong Cancer InstitutesAustin, TX
—
78
UofL James Graham Brown Cancer CenterLouisville, KY
—
79
Legorreta Cancer Center at Brown UniversityProvidence, RI
—
80
Upstate Cancer CenterSyracuse, NY
—
81
Mays Cancer Center at UT Health San Antonio MD AndersonSan Antonio, TX
NCI Clinical
—
82
Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA
NCI Comprehensive
—
83
University of Michigan Rogel Cancer CenterAnn Arbor, MI
NCI Comprehensive
—
84
UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC
NCI Comprehensive
—
85
Robert H. Lurie Comprehensive Cancer Center of Northwestern UniversityChicago, IL
NCI Comprehensive
—
86
Herbert Irving Comprehensive Cancer CenterNew York, NY
NCI Comprehensive
—
87
UC San Diego Moores Cancer CenterLa Jolla, CA
NCI Comprehensive
—
88
Mount Sinai Tisch Cancer CenterNew York, NY
NCI Comprehensive
—
89
UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA
NCI Comprehensive
—
90
Sandra and Edward Meyer Cancer Center at Weill Cornell MedicineNew York, NY
—
91
USC Norris Comprehensive Cancer CenterLos Angeles, CA
NCI Comprehensive
—
92
Montefiore Einstein Comprehensive Cancer CenterBronx, NY
NCI Comprehensive
—
93
UC Davis Comprehensive Cancer CenterSacramento, CA
NCI Comprehensive
—
94
Hollings Cancer CenterCharleston, SC
NCI Clinical
—
95
UCI Chao Family Comprehensive Cancer CenterOrange, CA
NCI Comprehensive
—
96
UK Markey Cancer CenterLexington, KY
NCI Comprehensive
—
97
Georgetown Lombardi Comprehensive Cancer CenterWashington, DC
NCI Comprehensive
—
98
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer CenterBaltimore, MD
NCI Comprehensive
—
99
Ellen and Ronald Caplan Cancer Center of The Wistar InstitutePhiladelphia, PA
NCI Basic_laboratory
—
100
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
—
101
GW Cancer CenterWashington, DC
—
102
Sanford Burnham Prebys Medical Discovery InstituteLa Jolla, CA
NCI Basic_laboratory
—
103
Cold Spring Harbor Laboratory Cancer CenterCold Spring Harbor, NY
NCI Basic_laboratory
—
104
Salk Institute Cancer CenterLa Jolla, CA
NCI Basic_laboratory
—
105
Ellis Fischel Cancer Center, MU Health CareColumbia, MO
—
106
WVU Cancer InstituteMorgantown, WV
—
107
UMMC Cancer Center and Research InstituteJackson, MS
—
108
Murtha Cancer Center at Walter Reed BethesdaBethesda, MD
—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →